Gene ontology (GO) enrichment analysis under high night-time temperatures with and without 1-MCP application. by Wardah K. Mustahsan (17484456)

Subjects:

Map of Harlingen, TX showing the location of the four study neighborhoods. by Jesús A. Aguilar-Durán (9931967)

Subjects:

<i>Aedes aegypti</i> database from SAGO traps. by Jesús A. Aguilar-Durán (9931967)

Subjects:

Weather conditions and variation in the numbers of female <i>Ae. aegypti</i> captured in SAGO traps. by Jesús A. Aguilar-Durán (9931967)

Subjects:

Average number of female <i><i>Ae</i></i>. <i><i>aegypti</i></i> in SAGOs traps per trap per week before and after treatments. by Jesús A. Aguilar-Durán (9931967)

Subjects:

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice... by Ananya Datta (19932144)

<i>Leptospira interrogans</i> from Okinawa induces epithelial barrier disruption with different kinetics. by Tetsuya Kakita (4922584)

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

Irradiation effect on <i>D. melanogaster</i> male sterility. GLM model values are shown. Values in boldface indicate significant differences (p < 0.05). by Flavia Cerasti (21655934)

Subjects:

Boxplot of the acoustic parameters of <i>Scinax x-signatus</i> in response to wind farm noise. The graphs show that calling males found in the ponds of the most intense noise class... by Rogério Ferreira de Oliveira (11133750)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …”

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects: